Earnings Ahead

ATRA - Atara Biotherapeutics, Inc.

1.71 0.03 1.79

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.

About

Profile


Headquarters

South San Francisco, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ATRA



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Atara Biotherapeutics GAAP EPS of -$0.82 misses by $0.03, revenue of $4.46M beats by $0.72M
  • Atara Biotherapeutics Q3 2022 Earnings Preview
  • EMA panel backs approval of Atara's Ebvallo for transplant complication
  • Atara Bio to get additional $30M milestone payment under collaboration with Pierre Fabre
  • Atara stock rises ~27% on Q2 beat, US regulatory path for tab-cel; to cut 20% staff
  • Atara Biotherapeutics GAAP EPS of $0.18 beats by $1.14, revenue of $51.58M beats by $45.05M
  • Atara Biotherapeutics Q2 2022 Earnings Preview
  • Atara slips as Citi downgrades to Sell on data for multiple sclerosis therapy
  • Atara plunges 56% as Stifel downgrades after early data for multiple sclerosis drug
  • Atara sinks on interim analysis of phase 2 study for multiple sclerosis candidate
  • Atara adds 16% ahead of Phase 2 data for multiple sclerosis candidate
  • Bluebird Bio, Clovis Oncology, Chimerix drop as Truist flags liquidity concerns
  • Atara price target lowered at H.C. Wainwright as partnership with Bayer ends
  • Bayer to end collaboration with Atara Biotherapeutics to develop CAR T-cell therapies
  • Atara Biotherapeutics falls 16% following Citi downgrade to neutral
  • Atara Biotherapeutics GAAP EPS of -$0.87 beats by $0.14, revenue of $7.31M beats by $2.98M
  • Atara Biotherapeutics Q1 2022 Earnings Preview
  • Atara Biotherapeutics names new technical chief
  • Atara Biotherapeutics GAAP EPS of -$0.96 misses by $0.37, revenue of $7.55M misses by $27.59M
  • Atara Biotherapeutics Q4 2021 Earnings Preview
Date Price Open High Low Vol Change ER
Oct 9, 2023 1.51 1.4
1.54
1.33
2.4M 7.09%
Oct 6, 2023 1.41 1.37
1.44
1.34
1.1M 0.71%
Oct 5, 2023 1.4 1.35
1.41
1.33
788K 0.72%
Oct 4, 2023 1.39 1.48
1.48
1.32
1.8M -7.33%
Oct 3, 2023 1.5 1.48
1.54
1.44
1.4M 0%
 
Oct 2, 2023 1.5 1.51
1.53
1.45
1.3M 1.35%
Sep 29, 2023 1.48 1.53
1.53
1.45
1.0M -3.27%
Sep 28, 2023 1.53 1.54
1.55
1.43
742K 0.66%
Sep 27, 2023 1.52 1.58
1.64
1.5
774K -3.18%
Sep 26, 2023 1.57 1.64
1.78
1.56
1.1M -3.68%
Sep 25, 2023 1.63 1.74
1.77
1.61
1.1M -8.94%
Sep 22, 2023 1.79 1.8
1.86
1.73
1.3M 0.56%
Sep 21, 2023 1.78 1.71
1.95
1.63
2.1M 1.14%
Sep 20, 2023 1.76 1.69
1.96
1.64
3.3M 11.39%
Sep 19, 2023 1.58 1.56
1.61
1.51
523K 1.28%
Sep 18, 2023 1.56 1.51
1.58
1.47
1.4M 1.96%
Sep 15, 2023 1.53 1.56
1.56
1.48
965K 0%
Sep 14, 2023 1.53 1.49
1.58
1.48
832K 3.38%
Sep 13, 2023 1.48 1.58
1.58
1.47
528K -5.13%
Sep 12, 2023 1.56 1.65
1.73
1.54
734K -7.14%
Sep 11, 2023 1.68 1.55
1.7
1.53
854K 9.80%
Sep 8, 2023 1.53 1.55
1.55
1.5
464K -0.65%
Sep 7, 2023 1.54 1.57
1.57
1.47
517K -1.91%
Sep 6, 2023 1.57 1.52
1.58
1.5
515K 3.97%
Sep 5, 2023 1.51 1.55
1.6
1.49
707K -2.58%
Sep 1, 2023 1.55 1.47
1.59
1.44
651K 6.16%
Aug 31, 2023 1.46 1.45
1.54
1.43
1.1M 0%
Aug 30, 2023 1.46 1.51
1.53
1.44
724K -3.31%
Aug 29, 2023 1.51 1.53
1.58
1.48
1.1M -0.66%
Aug 28, 2023 1.52 1.44
1.54
1.43
749K 7.04%
Aug 25, 2023 1.42 1.47
1.49
1.4
2.6M -5.33%
Aug 24, 2023 1.5 1.51
1.53
1.47
772K -0.66%
Aug 23, 2023 1.51 1.45
1.56
1.45
829K 3.42%
Aug 22, 2023 1.46 1.42
1.47
1.39
884K 3.55%
Aug 21, 2023 1.41 1.5
1.5
1.25
2.6M -5.37%
Aug 18, 2023 1.49 1.56
1.62
1.49
1.0M -6.88%
Aug 17, 2023 1.6 1.68
1.7
1.52
1.9M -5.33%
Aug 16, 2023 1.69 1.84
1.87
1.68
1.3M -8.15%
Aug 15, 2023 1.84 1.97
1.98
1.83
972K -6.6%
Aug 14, 2023 1.97 2.08
2.09
1.92
857K -5.74%
Aug 11, 2023 2.09 2.14
2.15
1.99
708K -4.13%
Aug 10, 2023 2.18 1.92
2.32
1.89
1.7M 15.96%
Aug 9, 2023 1.88 2.16
2.16
1.82
1.3M -17.18%
Aug 8, 2023 2.27 2.24
2.36
2.14
929K 0.89%
Aug 7, 2023 2.25 2.41
2.43
2.23
1.6M -2.17%
Aug 4, 2023 2.3 2.32
2.54
2.29
2.2M -0.43%
Aug 3, 2023 2.31 2.09
2.4
2.07
1.9M 10%
Aug 2, 2023 2.1 2.09
2.14
2
1.1M -2.33%
Aug 1, 2023 2.15 2.24
2.24
2.09
959K -2.71%
Jul 31, 2023 2.21 2.1
2.32
2.1
1.6M 7.28%
Jul 28, 2023 2.06 1.84
2.08
1.83
1.9M 15.08%
Jul 27, 2023 1.79 1.96
1.98
1.79
715K -8.21%
Jul 26, 2023 1.95 1.92
2.04
1.89
612K 1.56%
Jul 25, 2023 1.92 2.02
2.09
1.91
695K -5.88%
Jul 24, 2023 2.04 2.12
2.12
2
784K -2.86%
Jul 21, 2023 2.1 2.08
2.23
2.07
1.5M 1.45%
Jul 20, 2023 2.07 2.12
2.13
1.92
932K -2.36%
Jul 19, 2023 2.12 2.07
2.22
2.04
1.1M 3.41%
Jul 18, 2023 2.05 1.94
2.14
1.93
919K 5.13%
Jul 17, 2023 1.95 1.85
1.97
1.78
882K 0%